Scientific Talks
Webinar | June 5th 2025
13h WET/14h CET/15h EETJoin us for an insightful webinar on the integrated diagnosis of prostate cancer, a disease affecting over 1.4 million men annually and contributing to around 375,000 deaths each year. With advancements in early detection, survival rates have significantly improved, with nearly 98% of men surviving five years post-diagnosis.
In this session, we will explore the critical role of integrated diagnostic strategies, including epidemiology, clinical assessment, laboratory tests, and advanced imaging techniques. We will also dive into the importance of accurate staging and how imaging options can enhance diagnosis, guiding treatment decisions.
Don't miss this opportunity to learn about comprehensive approaches to prostate cancer detection, ensuring better patient outcomes and personalized care. Together, we can deepen our understanding and improve the lives of those affected by this common yet complex disease.

Scientific Programme
(Time zone CET) Moderator:M.Dziuk14.00pm – Welcome & Opening | A. Roncacci & R. Santos
14.05pm – Prostate Cancer Epidemiology and Clinical Insights | R. Sosnowski
14.20pm – Decoding PSA Tests| S. Fernandes
14.30pm – Precision Imaging in Prostate Cancer: The Role of Multiparametric MRI | H. Falińska & P. Stajgis
15.05pm – Prostate Cancer Imaging in PET/CT | M. Dziuk
15.25pm – PET/CT in Prostate Cancer Diagnosis: Are We There Yet? | E. Witkowska-Patena
15.45pm - Q&A
16.05pm - Closing remarks | M. Dziuk & R.Santos

Expected Education Outcomes
- To understand the clinical indications for each diagnostic modality, including pros & cons of each modality in prostate cancer, according to different clinical scenarios.
- To understand the role of MRI in the diagnostic pathway and the importance of pre-operative prostate MRI.
- To know which findings the radiologists must assess for clinical decision-making
- To become familiarised with the key updates on the prostate MRI findings, including: − Standardized Interpretation in prostate MRI assessment
- The impact of identifying and communicating findings in prostate cancer on patient management.
- The role of the radiologist as a central contributor for achieving best practices in the clinical care pathway and the added-value of communication within multidisciplinary teams.
− Recognizing Changes – Understanding refinements in transition zone (TZ) and peripheral zone (PZ) lesion scoring
− DWI & ADC Emphasis – Emphasizing the role of diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) in lesion characterization.
− Integration with clinical data
− In bore biopsy
− Avoiding Pitfalls

CME Information
The Deep Dive with Experts in Prostate Cancer - Integrated Diagnosis, Virtual, Netherlands 05/06/2025 - 05/06/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 2.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Registrations

Target Audience
- Doctors from every medical specialty who deal with prostate diseases;
- Residents;
- Other healthcare professionals with an interest in this field – Radiographers, Lab Technicians, Nurses.

Faculty
Alessandro Roncacci Radiologist MD, Chief Medical Officer | Affidea Group
Hanna Falińska Radiologist MD, Medical Director Deputy for Radiology, Poland, European Society Urogenital Radiology Prostate Working Group Member | Affidea Poland
Ewa Witkowska-Patena Specialist in Nuclear Medicine Prof. Ph.D. n. med. | Affidea Poland
Mirosław Dziuk Specialist in Nuclear Medicine Prof. Ph.D. n. med. | Affidea Poland
Piotr Stajgis Radiologist MD, PhD, Medical Chief Affidea Poznań | Affidea Poland
Roman Sosnowski Urologist, Head of Department of Urology and Oncological Urology Warmian-Masurian Cancer Center, Olsztyn, Poland
Rosana Santos Radiologist MD, President of the College of Radiology at the Portuguese Medical Association, Portuguese Deputy for Radiology at UEMS, Catolica Medical School, Clinical Education Scientific Leader | Affidea Group
Sérgio Fernandes Licenciate degree in Applied Chemistry-Biothecnology, Post-graduate in Medical Microbiology, Master’s degree in Public Health, Labs/Pathology Subspecialty Leader | Affidea Group

Organizing Committee:
Alessandro Roncacci Senior Vice President CMO, Affidea Group
Chryssa Paraskevopoulou Medical Physics and Radiation Protection Expert, Dose Management & Radiation Protection Manager, Affidea Group
Inês Ferreira Clinical Education Projects Coordinator, Affidea Group
Mirosław Dziuk Subspecialty Leader for Nuclear Medicine, Affidea Group
Rosana Santos Clinical Education Scientific Leader, Affidea Group

Previous Webinars:
Challenges in Prostate Cancer: Screening and early DiagnosisExpanding Teleradiology across Affidea
Critical Findings in Thoracic Imaging: expect the unexpected
Liver Imaging Update
The key to succeed in the Lab: Pre-Analytical Phase
Contrast Agents in Diagnostic Imaging: Myths and Truths - Iodine & Gadolinium
Critical Findings in Abdominal Imaging: expect the unexpected
Update on Breast Care
Clinical Research as a Care Option
Unlocking Dermatology: Strategies for identifying Skin Lesions and Building a Succcessful Dermatology Practice
Courses:
MRI Cardiac Course 2nd editionAdvanced Ultrasound Course
